|
FY2015
12 months to Sep 30, 2015
|
FY2014
12 months to Sep 30, 2014
|
FY2013
12 months to Sep 30, 2013
|
FY2012
12 months to Sep 30, 2012
|
FY2011
12 months to Sep 30, 2011
|
|
|---|---|---|---|---|---|
| Cash flows provided (used) by operating activities from continuing operations | |||||
| Net income | |||||
| Income from discontinued operations (net of tax) | |||||
| Adjustments to reconcile income from continuing operations to cash flows from operating activities | |||||
| Depreciation and amortization | |||||
| Debt issuance cost amortization | |||||
| Purchased in-process research and development impairment | |||||
| Deferred income taxes | |||||
| Equity income from affiliates | |||||
| Distributions from equity affiliates | |||||
| Gain from sale of property and equipment | |||||
| Stock-based compensation expense - Note P | |||||
| Stock contributions to qualified savings plans | |||||
| Net loss (gain) on acquisitions and divestitures - Notes B and C | |||||
| Loss on early retirement of debt | |||||
| Proceeds (repayment) from short-term debt | |||||
| Repurchase of common stock | |||||
| Debt issuance costs | |||||
| Cash dividends paid | |||||
| Proceeds from exercise of stock options | |||||
| Excess tax benefits related to share-based payments | |||||
| Total cash flows used by financing activities from continuing operations | |||||
| Cash used by continuing operations | |||||
| Cash provided (used) by discontinued operations | |||||
| Operating cash flows | |||||
| Investing cash flows | |||||
| Total cash provided by discontinued operations | |||||
| Effect of currency exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of year | |||||
| Cash and cash equivalents - end of year | |||||
| Changes in assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current and noncurrent assets | |||||
| Trade and other payables | |||||
| Other assets and liabilities | |||||
| Gain on available-for-sale securities | |||||
| Net loss (gain) on divestitures - Note B | |||||
| Inventory fair value adjustment related to ISP acquisition | |||||
| Impairments of equity method investment and in-process research and development | |||||
| Pension contributions | |||||
| Other current and noncurrent liabilities | |||||
| Losses (gains) on pension and postretirement plan remeasurement | |||||
| Change in operating assets and liabilities | |||||
| Supplemental disclosures | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Total cash flows provided by operating activities from continuing operations | |||||
| Cash flows provided (used) by investing activities from continuing operations | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from disposal of property, plant, and equpment | |||||
| Purchase of operations - net of cash acquired | |||||
| Proceeds (uses) from sale of operations or equity investments | |||||
| Proceeds from sale of available-for-sale securities | |||||
| Purchase of available-for-sale securities | |||||
| Funds restricted for specific transactions | |||||
| Reimbursement from restricted investments | |||||
| Proceeds from the settlement of derivative instruments | |||||
| Payments for the settlement of derivative instruments | |||||
| Total cash flows used by investing activities from continuing operations | |||||
| Cash flows provided (used) by financing activities from continuing operations | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
Loading...
